Ligand profile
RXV
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02784 — DNA topoisomerase 4 subunit A
Identifiers
Database identifiers and provenance.
- Ligand ID
RXV- PDB
2xcr- UniProt (similar protein)
Q99XG5- Target protein
- KP13_02784
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 83.3
- −1 ≤ LogP ≤ 5 3.75
- MW ≤ 500 Da 461.6
- LogP ≤ 5 3.75
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 83.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1ccc2c(c1)c(c(cn2)C#N)CCN3CCC(CC3)NCc4cc5c(cn4)OCS5COc1ccc2c(c1)c(c(cn2)C#N)CCN3CCC(CC3)NCc4cc5c(cn4)OCS5
InChI=1S/C25H27N5O2S/c1-31-20-2-3-23-22(11-20)21(17(12-26)13-29-23)6-9-30-7-4-18(5-8-30)27-14-19-10-25-24(15-28-19)32-16-33-25/h2-3,10-11,13,15,18,27H,4-9,14,16H2,1H3InChI=1S/C25H27N5O2S/c1-31-20-2-3-23-22(11-20)21(17(12-26)13-29-23)6-9-30-7-4-18(5-8-30)27-14-19-10-25-24(15-28-19)32-16-33-25/h2-3,10-11,13,15,18,27H,4-9,14,16H2,1H3
NKXJSCXEAVZSMF-UHFFFAOYSA-NNKXJSCXEAVZSMF-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00521
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand RXV →
- PDB RCSB structure 2xcr →
- UniProt UniProt Q99XG5 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “RXV”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02784.
PDB 22
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).